Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-12-23
2011-11-22
Dell, David K O (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C544S382000, C546S195000, C514S617000, C514S255010, C514S195000
Reexamination Certificate
active
08063248
ABSTRACT:
The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
REFERENCES:
patent: 3352912 (1967-11-01), William
patent: 3657273 (1972-04-01), Krimmel
patent: 3663565 (1972-05-01), Krimmel
patent: 4053509 (1977-10-01), Faro et al.
patent: 4332806 (1982-06-01), Atsumi et al.
patent: 4349552 (1982-09-01), Takaya et al.
patent: 5595995 (1997-01-01), Chan et al.
patent: 6649600 (2003-11-01), Kiesman et al.
patent: 2004/0034075 (2004-02-01), Smith
patent: 2006/0270630 (2006-11-01), Smith et al.
patent: 2006/0270631 (2006-11-01), Smith et al.
patent: WO 99/26927 (1999-06-01), None
patent: WO 2004/089470 (2004-10-01), None
patent: WO 2006/048750 (2006-05-01), None
patent: WO 2006/100502 (2006-09-01), None
Danilenko, G. I.; Votyakov, V. I.; Andreeva, O. T.; Shashikhina, M. N.; Timofeeva, M. M.; Denisova, L. V.; Boreko, E. I.; Novikova, M. I. Synthesis and biological activity of adamantane derivatives. V. Virus-inhibiting effect of arylamides of adamantanecarboxylic acids. Khimiko-Farmatsevticheskii Zhurnal, 10(7), 60-2 1976, translation.
Xiang et. al. “Discovery of novel sphingosine kinase-1 inhibitors. Part 2” Bioorganic & Medicinal Chemistry Letters 2010, 20, 4550-4554.
Silverman, R.B. The Organic Chemistry of Drug Design and Drug Action 1992, Academic: New York, p. 19.
Salvatore et al., Cesium Effect: High Chemoselectivity in Direct N-Alkylation of Amines, J. Org. Chem, 2002, 67, 674-683.
International Search Report for PCT/US 2006/023645.
Danilenko, G.N. et al: “Synthesis and Biological Activity of Adamantane Derivatives”, Pharmaceutical Chemistry Journal English Translation of Khimiko—Farmatsevticheskii Zhurnal, vol. 7, No. 10, pp. 621-622, Oct. 1973.
Safonova, O.A. et al.; “Synthesis and Biological Activity of 5-(Adamant-1-yl) Salicylic Acid, 3-(4-Hydroxphenyl) Adamantanecarboxylic Acid and Some of their Derivatives”, Translated from Khimiko-farmatsevticheskii Zhurnal, vol. 23, No. 9, pp. 1094-1098, Sep. 1989.
Handa, Indra et al.; “Synthesis of 3-Aryl-1-adamantanemethylamines”, J. Chem. Eng. vol. 29, pp. 223-225, 1984.
Danilenko, G. I. et al.; “Bacterostatic effect of adamantanecarboxylic acids”, Fiziologicheski Akivnye Veschchestva, Chemical Abstracts Accession No. 1975:496537, vol. 7, pp. 144-147, (1966-1992) (1975).
Pozdnyakov, V. V. et al.; “Synthesis and Reactivity of 3-R-1-Adamantyl Methyl Ketones”, Russian Journal of Organic Chemistry, vol. 37, No. 9, pp. 1128-1231, 2001.
Fytas, George et al.; “3-Cyclopentyl-1-Adamantanamines and Adamantanemethanamines. Antiviral Activity Evaluation and Convulsions Studies”, IL Farmaco, vol. 49, No. 10, pp. 641-647, 1994.
Stepanov, F. N. et al.: “Adamantane and its derivatives. XXV. Reaction of bromomethyl ketones of adamantanes with formamide and aniline”, Translated from Zhurnal Organicheskol Khimii, vol. 6, No. 6, pp. 1195-1198, 1970.
Scvekhgeimer, G.A. et al.;“Synthesis and properties of azoles and their derivatives. XXX. Synthesis of heterocyclic compounds based on adamantane-1,3-dicarboxylic acid dinitrile; Khimiya Geterotsiklicheskikd Soedinenii”, vol. 12, pp. 1654-1657, 1976.
Kontonassios, Demetrios et al.; “3-(Dialkylamino)methyladamantane-1-carboxylic Acids”, Journal of Medical Chemistry, vol. 12, No. 1, pp. 170-172, Jan. 1969.
“R-5.7.8 Amides, imides, and hydrazides” online “http://www.acdlabs.com/iupac
omenclature/93/r93—543.htm”, May 2, 2007.
Ferdinand C.Y. et al., “3- and 4-Pyridylalkyl Adamantanecarboxylates: Inhibitors of Human Cytochrome P450”. . . “Potential Nonsteroidal Agents for the Treatment of Prostatic Cancer”, vol. 39, pp. 3319-3323, 1996.
Price, Charles; “The alkylation of aromatic compounds by the Friedel-crafts method”, In Organic Reactions vol. III, Wiley: New York, pp. 1-19, 1947.
Handa, I. et al.; Journal of Chemical Engineering Data 1984, vol. 29, pp. 223-225.
Frisherman, R.B. et al.; “N-Methylstearylamides of adamantanecarboxylic acids”, U.S.S.R. Otkrytiya, Izobret., Prom. Obraztsy, Tovarnye Znaki, vol. 51, No. 44, pp. 51-52, 1974.
No, B.I. et al.; “Synthesis of N, N′-diphenyl-1-1,3-adamantanebis (carboximidoyl chloride) and adamantanebis (carboximidates)”, Russian Journal of General Chemistry (Translation of Zhurnal Obschei Khimii), vol. 69, No. 5, pp. 843-844, 1999.
Horvat, {hacek over (S)}tefica; “Tumor-Cell-Targeted Methionine-enkephalin Analogues Containing Unnatural Amino Acids: Design, Synthesis, and in Vitro Antitumor Activity”, J. Med. Chem., vol. 49, pp. 3136-3142, 2006.
SciFinder substructure search results, aminoethylpyridine, performed Aug. 9, 2007, 26 pages.
SciFinder substructure search results, aminomethylpyridine (commercially available only), performed Aug. 9, 2007, 21 pages.
El-Sherbeny M. A.; “Adamantane Derivatives, Part II: Synthesis DNA Binding and Antitumor Evaluation;” Medical Chemistry Research 2002 United States, vol. 11, No. 2, pp. 74-86, 2002.
Kozlov N.G. et al.; “Reductive Amination of 1-Acetyladamantane with Nitriles”, Chemical Abstracts Service, Columbus, OH, retrieved from STN Database accession No. 1985:804596.
Markarova, N.V. et al.; “Dimethyl Adamantoylmalonate: New Intermediate in the Synthesis of 1-Acetyladamantane”, Russian Journal of Organic Chemistry.
Melindez et al.; “Sphingosine kinase signalling in immune cells: Potential as novel therapeutic targets”, Biochimica et Biophysica Acta 2007, in press.
Johnson, A.W.; “Invitation to Organic Chemistry 1999 Jones and Bartlett”, Mississauga, Canada, pp. 24.
Hal Bender; “Nomenclature”, Clackamas Community College online: “http://dl.clackamas.cc.or.us/ch106-05
omencla1.htm2003”, May 5, 2007.
French Kevin J.
Smith Charles D.
Zhuang Yan
Apogee Biotechnology Corporation
Dell David K O
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
Sphingosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sphingosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sphingosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4309709